title: Molecular studies of alpha-2-adrenoceptor and catecholamine-insensitive imidazoline-receptor binding sites using [3H]-rilmenidine in rat brain and kidney.
authors.affiliation: University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
authors.forename: P R
authors.initials: PR
authors.lastname: King
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: T L
authors.initials: TL
authors.lastname: Nero
authors.forename: A L
authors.initials: AL
authors.lastname: Gundlach
authors.forename: W J
authors.initials: WJ
authors.lastname: Louis
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D054755:Imidazoline Receptors; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism; D010080:Oxazoles / Q000378:metabolism*; D051381:Rats; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D000077769:Rilmenidine; D014018:Tissue Distribution
chemical_list: D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D002395:Catecholamines; D054755:Imidazoline Receptors; D010080:Oxazoles; D018341:Receptors, Adrenergic, alpha-2; D011955:Receptors, Drug; D000077769:Rilmenidine